159 related articles for article (PubMed ID: 28008934)
21. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
Narayan S; Bader GD; Reimand J
Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
[TBL] [Abstract][Full Text] [Related]
22. Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration.
Parsana P; Amend SR; Hernandez J; Pienta KJ; Battle A
BMC Cancer; 2017 Jun; 17(1):447. PubMed ID: 28651527
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatics analysis of thousands of TCGA tumors to determine the involvement of epigenetic regulators in human cancer.
Gnad F; Doll S; Manning G; Arnott D; Zhang Z
BMC Genomics; 2015; 16 Suppl 8(Suppl 8):S5. PubMed ID: 26110843
[TBL] [Abstract][Full Text] [Related]
24. Rational design of cancer gene panels with OncoPaD.
Rubio-Perez C; Deu-Pons J; Tamborero D; Lopez-Bigas N; Gonzalez-Perez A
Genome Med; 2016 Oct; 8(1):98. PubMed ID: 27716338
[TBL] [Abstract][Full Text] [Related]
25. OncodriveROLE classifies cancer driver genes in loss of function and activating mode of action.
Schroeder MP; Rubio-Perez C; Tamborero D; Gonzalez-Perez A; Lopez-Bigas N
Bioinformatics; 2014 Sep; 30(17):i549-55. PubMed ID: 25161246
[TBL] [Abstract][Full Text] [Related]
26. Integrative modeling of multi-omics data to identify cancer drivers and infer patient-specific gene activity.
Pavel AB; Sonkin D; Reddy A
BMC Syst Biol; 2016 Feb; 10():16. PubMed ID: 26864072
[TBL] [Abstract][Full Text] [Related]
27. An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC).
Wang Y; Guo X; Bray MJ; Ding Z; Zhao Z
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):515. PubMed ID: 27556922
[TBL] [Abstract][Full Text] [Related]
28. Predicting the functional consequences of somatic missense mutations found in tumors.
Carter H; Karchin R
Methods Mol Biol; 2014; 1101():135-59. PubMed ID: 24233781
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers.
Zhang Y; Xu Y; Feng L; Li F; Sun Z; Wu T; Shi X; Li J; Li X
Oncotarget; 2016 Sep; 7(39):64148-64167. PubMed ID: 27580177
[TBL] [Abstract][Full Text] [Related]
30. CRAC channels, calcium, and cancer in light of the driver and passenger concept.
Hoth M
Biochim Biophys Acta; 2016 Jun; 1863(6 Pt B):1408-17. PubMed ID: 26705695
[TBL] [Abstract][Full Text] [Related]
31. A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma.
Shohet JM; Ghosh R; Coarfa C; Ludwig A; Benham AL; Chen Z; Patterson DM; Barbieri E; Mestdagh P; Sikorski DN; Milosavljevic A; Kim ES; Gunaratne PH
Cancer Res; 2011 Jun; 71(11):3841-51. PubMed ID: 21498633
[TBL] [Abstract][Full Text] [Related]
32. Oncogenes and tumor suppressor genes: comparative genomics and network perspectives.
Zhu K; Liu Q; Zhou Y; Tao C; Zhao Z; Sun J; Xu H
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S8. PubMed ID: 26099335
[TBL] [Abstract][Full Text] [Related]
33. Integrating omics data and protein interaction networks to prioritize driver genes in cancer.
Zhang T; Zhang D
Oncotarget; 2017 Aug; 8(35):58050-58060. PubMed ID: 28938536
[TBL] [Abstract][Full Text] [Related]
34. SSA-ME Detection of cancer driver genes using mutual exclusivity by small subnetwork analysis.
Pulido-Tamayo S; Weytjens B; De Maeyer D; Marchal K
Sci Rep; 2016 Nov; 6():36257. PubMed ID: 27808240
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic analysis in the search for tumor suppressor genes.
Han ZG
Epigenomics; 2010 Aug; 2(4):489-93. PubMed ID: 22121966
[No Abstract] [Full Text] [Related]
36. Pan-cancer detection of driver genes at the single-patient resolution.
Nulsen J; Misetic H; Yau C; Ciccarelli FD
Genome Med; 2021 Feb; 13(1):12. PubMed ID: 33517897
[TBL] [Abstract][Full Text] [Related]
37. [Tumor suppressors--genes and proteins].
Lothe RA; Blomhoff HK
Tidsskr Nor Laegeforen; 1998 May; 118(12):1887-92. PubMed ID: 9638059
[TBL] [Abstract][Full Text] [Related]
38. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.
Chandrashekar DS; Bashel B; Balasubramanya SAH; Creighton CJ; Ponce-Rodriguez I; Chakravarthi BVSK; Varambally S
Neoplasia; 2017 Aug; 19(8):649-658. PubMed ID: 28732212
[TBL] [Abstract][Full Text] [Related]
39. Sequence Neighborhoods Enable Reliable Prediction of Pathogenic Mutations in Cancer Genomes.
Banerjee S; Raman K; Ravindran B
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34068918
[TBL] [Abstract][Full Text] [Related]
40. miRNA-15a/16: as tumor suppressors and more.
Huang E; Liu R; Chu Y
Future Oncol; 2015; 11(16):2351-63. PubMed ID: 26260813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
